Christine Ravinet Trillou

Summary

Affiliation: Sanofi-Synthelabo Recherche
Country: France

Publications

  1. ncbi Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice
    Christine Ravinet Trillou
    Central Nervous System Research, Sanofi Synthelabo, 31036 Toulouse Cedex, France
    Am J Physiol Regul Integr Comp Physiol 284:R345-53. 2003
  2. ncbi CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity
    C Ravinet Trillou
    Central Nervous System Research, Sanofi Synthelabo, Toulouse Cedex, France
    Int J Obes Relat Metab Disord 28:640-8. 2004

Detail Information

Publications2

  1. ncbi Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice
    Christine Ravinet Trillou
    Central Nervous System Research, Sanofi Synthelabo, 31036 Toulouse Cedex, France
    Am J Physiol Regul Integr Comp Physiol 284:R345-53. 2003
    ..SR141716 had no effect in CB1 receptor knockout mice, which confirmed the implication of CB1 receptors in the activity of the compound. These findings suggest that SR141716 has a potential as a novel anti-obesity treatment...
  2. ncbi CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity
    C Ravinet Trillou
    Central Nervous System Research, Sanofi Synthelabo, Toulouse Cedex, France
    Int J Obes Relat Metab Disord 28:640-8. 2004
    ..To further define the physiological role of these receptors in the control of energy balance, we characterized the phenotype of CB1 receptor knockout (CB1(-/-)) mice maintained on an obesity-prone regimen or on a standard chow...